Eli Lilly ( LLY 0.64%) has been one of the best-performing pharmaceutical leaders in the past five years. Thanks to strong ...

Obesity has become a global epidemic, contributing to a host of chronic health conditions such as type 2 diabetes, hypertension, and cardiovascular disease.

Demand for glucagon-like peptide-1 weight-loss drugs — such as Ozempic, Zepbound and Wegovy — coupled with limited insurance coverage has fueled a risky but growing “gray” market for purchasing active ...

A new study in mice shows that tirzepatide—the active ingredient in the popular drugs Mounjaro and Zepbound—not only helps shed pounds but may also slow or reduce the growth of breast cancer tumors ...

Tirzepatide was superior to semaglutide in achieving standard and intensive cardiometabolic targets among patients with type 2 diabetes.

Do-it-yourself dental hacks have been trending online. However, we spoke with a dentist that warned of the dangers they can bring.

DIY tirzepatide, internet detective work and insurance appeals: The lengths 3 people are going to for weight loss drugs "Not being on it is not an option." ...

Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to access life-changing weight loss medications.

Lilly’s tirzepatide shortage ended first, with the FDA officially declaring the situation resolved early last October. The regulator erased Novo’s semaglutide from its shortage list in February.

One comes mixed with tirzepatide, the active ingredient in Eli Lilly's Zepbound ... according to import data and social media postings. It's a trend that drugmakers Lilly and Novo Nordisk, which makes ...

Among the hundreds of games on sale during the Steam Summer Sale, these are the ones you don't want to miss.